- Home
- GCI vs PRME Comparison
GCI vs PRME Comparison
Compare GCI & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCI
- PRME
- Stock Information
- Founded
- GCI 1997
- PRME 2019
- Country
- GCI United States
- PRME United States
- Employees
- GCI N/A
- PRME N/A
- Industry
- GCI Newspapers/Magazines
- PRME Medicinal Chemicals and Botanical Products
- Sector
- GCI Consumer Discretionary
- PRME Health Care
- Exchange
- GCI Nasdaq
- PRME Nasdaq
- Market Cap
- GCI 612.9M
- PRME 693.5M
- IPO Year
- GCI N/A
- PRME 2022
- Fundamental
- Price
- GCI $4.28
- PRME $4.65
- Analyst Decision
- GCI Buy
- PRME Buy
- Analyst Count
- GCI 3
- PRME 6
- Target Price
- GCI $5.70
- PRME $8.88
- AVG Volume (30 Days)
- GCI 1.2M
- PRME 2.9M
- Earning Date
- GCI 10-30-2025
- PRME 11-11-2025
- Dividend Yield
- GCI N/A
- PRME N/A
- EPS Growth
- GCI N/A
- PRME N/A
- EPS
- GCI 0.73
- PRME N/A
- Revenue
- GCI $2,390,148,000.00
- PRME $4,961,000.00
- Revenue This Year
- GCI N/A
- PRME $179.58
- Revenue Next Year
- GCI N/A
- PRME N/A
- P/E Ratio
- GCI $6.00
- PRME N/A
- Revenue Growth
- GCI N/A
- PRME 739.42
- 52 Week Low
- GCI $2.55
- PRME $1.11
- 52 Week High
- GCI $5.93
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- GCI 55.47
- PRME 67.08
- Support Level
- GCI $4.02
- PRME $3.09
- Resistance Level
- GCI $4.42
- PRME $4.18
- Average True Range (ATR)
- GCI 0.14
- PRME 0.33
- MACD
- GCI 0.01
- PRME 0.12
- Stochastic Oscillator
- GCI 61.80
- PRME 80.00
About GCI Gannett Co. Inc.
Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.